| Dale J Meyer, MD | |
|
8450 Seasons Pkwy, Mail Stop 32900a, Woodbury, MN 55125-4402 | |
| (651) 702-5300 | |
| (651) 702-5305 |
| Full Name | Dale J Meyer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 8450 Seasons Pkwy, Woodbury, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023089430 | NPI | - | NPPES |
| 324005300 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 33128 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Regions Hospital | Saint paul, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, sleep selectively preservers memories that are emotionally salient and relevant to future goals when sleep follows soon after learning. Effects persist for as long as four months after the memory is created.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
A new study has shed light on a debilitating autoimmune condition by identifying a number of subtypes of the disease which could lead to personalised treatment for patients.
An exciting research project to utilise the body's own stem cells to regenerate areas of tissue damage is uniting scientists in Birmingham, London and Ontario, Canada. The University of Birmingham is leading a three year study with long term aims of helping stroke, Parkinsons and diabetes patients.
Healthland, America's market leader of healthcare information solutions for rural community and critical access hospitals, today announced it will host a live webcast as part of its ongoing commitment to provide community hospitals and affiliated clinics with tools and services to help them meet meaningful use requirements under the American Recovery and Reinvestment Act of 2009.
› Verified 2 days ago
| Entity Name | Group Health Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, sleep selectively preservers memories that are emotionally salient and relevant to future goals when sleep follows soon after learning. Effects persist for as long as four months after the memory is created.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
A new study has shed light on a debilitating autoimmune condition by identifying a number of subtypes of the disease which could lead to personalised treatment for patients.
An exciting research project to utilise the body's own stem cells to regenerate areas of tissue damage is uniting scientists in Birmingham, London and Ontario, Canada. The University of Birmingham is leading a three year study with long term aims of helping stroke, Parkinsons and diabetes patients.
Healthland, America's market leader of healthcare information solutions for rural community and critical access hospitals, today announced it will host a live webcast as part of its ongoing commitment to provide community hospitals and affiliated clinics with tools and services to help them meet meaningful use requirements under the American Recovery and Reinvestment Act of 2009.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dale J Meyer, MD 8170 33rd Ave S # Ms 21110q, Minneapolis, MN 55425-4516 Ph: () - | Dale J Meyer, MD 8450 Seasons Pkwy, Mail Stop 32900a, Woodbury, MN 55125-4402 Ph: (651) 702-5300 |
News Archive
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, sleep selectively preservers memories that are emotionally salient and relevant to future goals when sleep follows soon after learning. Effects persist for as long as four months after the memory is created.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
A new study has shed light on a debilitating autoimmune condition by identifying a number of subtypes of the disease which could lead to personalised treatment for patients.
An exciting research project to utilise the body's own stem cells to regenerate areas of tissue damage is uniting scientists in Birmingham, London and Ontario, Canada. The University of Birmingham is leading a three year study with long term aims of helping stroke, Parkinsons and diabetes patients.
Healthland, America's market leader of healthcare information solutions for rural community and critical access hospitals, today announced it will host a live webcast as part of its ongoing commitment to provide community hospitals and affiliated clinics with tools and services to help them meet meaningful use requirements under the American Recovery and Reinvestment Act of 2009.
› Verified 2 days ago
Marisa Ann Spencer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 237 Radio Dr Ste 210, Woodbury, MN 55125 Phone: 612-871-1145 Fax: 612-870-5491 | |
Rachel Elizabeth Kneeland, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4040 Radio Dr, Woodbury, MN 55129 Phone: 651-439-8807 Fax: 651-439-0232 | |
Lisa C Ramsay, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8675 Valley Creek Rd, Woodbury, MN 55125 Phone: 651-501-3028 Fax: 651-501-3049 | |
Dr. Ann Wendling, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6603 Crackleberry Trl, Woodbury, MN 55129 Phone: 651-459-3982 | |
Peter B Arnesen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1925 Woodwinds Dr, Woodbury, MN 55125 Phone: 651-232-0100 | |
Sou-pan Wu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4040 Radio Dr, Woodbury, MN 55129 Phone: 651-439-8807 Fax: 651-439-0232 |